Overall quarterly revenue was $92.7 million, up 8 percent from a year-earlier $86 million, as ‘Gladiator II,’ ‘Venom: The ...
Roth MKM analyst Eric Handler raised the firm’s price target on Imax (IMAX) to $32 from $30 and keeps a Buy rating on the shares. The ...
Barrington raised the firm’s price target on Imax (IMAX) to $32 from $28 and keeps an Outperform rating on the shares following the Q4 report.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results